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Abstract
The number of pathogens that are required to infect a host, termed infective dose, varies dramatically across pathogen
species. It has recently been predicted that infective dose will depend upon the mode of action of the molecules that
pathogens use to facilitate their infection. Specifically, pathogens which use locally acting molecules will require a lower
infective dose than pathogens that use distantly acting molecules. Furthermore, it has also been predicted that
pathogens with distantly acting immune modulators may be more virulent because they have a large number of cells in
the inoculums, which will cause more harm to host cells. We formally test these predictions for the first time using data
on 43 different human pathogens from a range of taxonomic groups with diverse life-histories. We found that pathogens
using local action do have lower infective doses, but are not less virulent than those using distant action. Instead, we
found that virulence was negatively correlated with infective dose, and higher in pathogens infecting wounded skin,
compared with those ingested or inhaled. More generally, our results show that broad-scale comparative analyses can
explain variation in parasite traits such as infective dose and virulence, whilst highlighting the importance of mechanistic
details.
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Introduction
There is huge variation across pathogen species in the number
of cells required to successfully infect a host. This number is
known as the ‘infective dose’. At one end of the scale, species such
as Shigella and Giardia lamblia require about 10 cells to start an
infection. In contrast, species such as Vibrio cholera and
Staphylococcus aureus require 10
3–10
8 cells in order for an infection
to develop [1–3]. It is unclear why infective dose varies, with
large differences occurring even between closely related patho-
gens [2,3].
Schmid-Hempel and Frank [2] predicted that the variation in
infective dose could be explained by the different biochemical
mechanisms that pathogens use to infect hosts. Pathogens secrete a
number of molecules which facilitate the suppression and/or
evasion of host immune responses, and hence aid parasite growth.
If these molecules act locally, in the vicinity of the pathogenic cell,
then only small numbers of molecules may be required for
successful growth and so infections can be established from small
numbers of pathogenic cells. In contrast, if the pathogenic
molecules diffuse and therefore act at a distance, then large
numbers of molecules may be required for evading the host
immune system. In these cases greater numbers of pathogenic cells
could be needed to establish an infection. However, while this
prediction is consistent with anecdotal data [2,3], it has yet to be
tested formally.
Here, we test Schmid-Hempel and Frank’s [2] prediction that
infective dose is determined by whether pathogenesis is locally or
distantly acting. We use data from 43 species of human pathogens
across a range of enteropathogenic bacteria, protozoa, fungi and
viruses. A possible problem with comparative studies across species
is that closely related species can share characters through
common descent rather than independent evolution. Consequent-
ly, analysing species as independent data points can lead to
misleading correlations [4–6]. For example, all viruses are locally
acting, and so this could lead to patterns between viruses and
bacteria, rather than local or distant action. We account for this
potential problem of shared ancestry by using multivariate nested
taxonomic models [7,8].
We then extend this work in two ways. First, Schmid-Hempel
and Frank [2,3,9] further predicted that pathogens with distantly
acting immune modulators will be more virulent, possibly because
they would have a large numbers of cells in the inoculums, and
higher parasite density would overwhelm the host immune system
causing more harm to hosts. We therefore test whether the
virulence of pathogens with distantly acting immune modulators is
greater than that of pathogens with locally acting molecules.
Second, we test the influence of two other factors that could affect
infective dose and virulence: mode of transmission (direct or
indirect) and route of infection (ingestion, inhalation or wounded
skin) [1,10–12]. These factors could influence dose and virulence
for a number of reasons, including their affect on: the extent to
which virulence reduces pathogen transmission; the types of
immune response they encounter; and the genetic diversity (or
relatedness) of the pathogens either competing for or cooperating
to exploit the host [2,3,9–28].
PLoS Pathogens | www.plospathogens.org 1 February 2012 | Volume 8 | Issue 2 | e1002512Results/Discussion
We found that pathogens with immune modulators that act
distantly within the host have significantly higher infective doses
than pathogens with locally acting molecules, (Figure 1 and Table
S2 in Text S1: F1, 40=25.79, P,0.0001). This supports the
prediction by Schmid-Hempel and Frank [2] that local pathogenic
action requires only a small number of molecules, and thus
relatively few cells are needed to start an infection, compared to
distantly acting mechanisms where a large number of diffusible
molecules need to accumulate in order to overwhelm the host’s
immune clearance.
Contrary to the hypothesis that pathogens with distantly acting
immune modulators are more virulent, we found no significant
relationship between case fatality rate or severity of infection and
the mechanism of pathogenesis (Table S3 and Table S4 in Text
S1: P.0.05). However, case fatality rate was significantly
negatively related to infective dose of pathogens (Figure 2 and
Table S3 in Text S1: F1, 38=3.94, P=0.05). We suggest this
correlation arises because for a given dose, pathogens that are
locally acting and have lower infective doses are more likely to
establish an infection. For this relationship to hold, we reasonably
assume that the actual dose in natural infections is largely
determined by factors such as mode of transmission, and so does
not show a strong covariance with whether a parasite acts locally
or globally within the host. We attempted to collect data on mean
parasite dose in different transmission modes during natural
infections so we could examine how this correlates with local/
global within-host parasite action, but we were unable to obtain
sufficient data.
There are at least two possible alternative explanations for the
negative relationship between case fatality rate and infective dose
of parasites, although we suggest these are less likely than the
above explanation. First, recent theory suggests parasites might
adapt to low infective doses by evolving a higher per-parasite
growth rate, causing greater host exploitation and virulence [29].
However, the reduction in dose in this model results from
increased host resistance, and there is no reason to assume that
selection for host resistance consistently differs between global and
local acting parasites.
Second, a low infective dose may reduce the incidence of
multiple genotype pathogen infections since there are fewer
parasites in the inoculum, which could favour higher levels of
cooperation between parasites, and hence lead to greater growth
and virulence [24,25]. However, the extent to which this will be of
general importance will be limited by the fact that different
biological details can lead to different relationships between strain
diversity and virulence. For example, when different parasite
strains compete for host resources, higher strain diversity is
expected to lead to greater virulence [10,11,22,29–33]. Alterna-
tively, antagonistic interaction between strains, such as chemical
warfare, can lead to a predicted domed relationship between strain
diversity and virulence [26]. Nonetheless, it is possible that all
three explanations could play a role, with their importance varying
across species.
We found that pathogens infecting hosts through wounded skin
result in significantly higher case fatality rates than pathogens
inhaled or ingested (Figure 3 and Table S3 in Text S1:
F2, 26=5.30, P=0.01). Given that infection via wounded skin
includes transmission via bites of insect vectors and contaminated
water, this result supports theory on virulence-transmission trade-
offs which proposes that vectors and water systems circumvent the
need for an ambulatory host to transmit pathogens, selecting for
the evolution of higher virulence [12,18,21]. However, another
potentially important factor is that the type of immune response
that pathogens are confronted with will affect virulence. Pathogens
that infect hosts through wounded skin evade mechanical
Figure 1. Infective dose and the mechanisms used by
pathogens to infect hosts. Means 61 standard error (Table S2 in
Text S1).
doi:10.1371/journal.ppat.1002512.g001
Figure 2. Variation in case fatality rate explained by infective
dose. Means 61 standard error. Line represents a logistic curve (Table
S3in Text S1).
doi:10.1371/journal.ppat.1002512.g002
Author Summary
We found that mechanisms used by parasites to infect
hosts are able to explain variation in two key pathogen
traits: infective dose and virulence. In pathogens where the
molecules secreted to facilitate infection acted locally, the
number of cells required to start an infection (infective
dose), was lower than in pathogens where the secreted
molecules act more distantly. Parasite virulence showed no
correlation with local versus distant action, but was
negatively correlated with infective dose, and greater in
species that infect via wounded skin. By showing how such
parasite life history details matter, our results help explain
why classical trade-off models have been relatively
unsuccessful in explaining broad scale variation across
parasite species.
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may cause virulent systemic infections more readily than ingested
or inhaled pathogens, which must overcome other anti-infection
barriers such as stomach acid and mucus membranes before
causing systemic infections.
More generally, our results emphasise the importance of life-
history or mechanistic details for the evolution of parasite traits.
Theoretical models for the evolution of parasite traits such as
virulence have generally relied on simple trade-offs between
virulence and transmission. These models have been able to
explain variation in virulence both within species, and between
closely related species with similar life histories [15,20,28,33–37].
In contrast, this body of theory has been less successful at
explaining broad scale variation across species [2,9,25,27]. One
possible explanation for this is that the predictions of virulence
theory can depend upon the mechanisms that parasites use to
infect and exploit hosts, which are not considered in the classical
models; hence our expectations of data fitting the model may be
too high. If the details of how parasites infect hosts really matter,
this would limit the extent to which we would expect to find broad
empirical patterns to match theory [25]. Our results show that
transmission, dose and virulence can be influenced by mechanistic
details such as distance at which molecules act and route of
infection.
Materials and Methods
Infective dose
We obtained data on the number of pathogen cells required to
start an infection (infective dose) by searching: (a) databases from
the United States Food and Drug Administration [38], Health
Canada [39], Medscape [40], the Centre for Disease Control and
Prevention [41], the World Health Organisation [42]; (b)
empirical studies found via keyword searches in the ISI Web of
Knowledge database [43]. Where ranges or more than one
estimate of infective dose were given, we calculated the median
infective dose to use in our analyses.
We emphasise that uncertainties exist in infective dose
measurements: often they were extrapolated from epidemiologic
investigations, were obtained by human feeding studies on healthy,
young adult volunteers, or are best or worst estimates based on a
limited data from outbreaks. Where known, we give methods of
estimation in Table S1 in Text S1.
Classifying mechanisms of pathogenesis
We classified pathogens as having local or distant action
according to the framework of Schmid-Hempel and Frank [2]. For
local action, pathogens directly interact with host cells via surface-
bound molecules or by injecting proteins into host cells by a type
III or IV secretion systems. For example, Yersinia entricolata/
tuberculosis injects Yop protein into target cells via a type III
secretion system, leading to cytotoxicity [44], and Ebola virus binds
to different cell surfaces and replicates leading to cell necrosis [45].
For distant action, pathogens indirectly interact with host cells
by secreting proteins that diffuse into their surroundings and only
exert pathogenic effects when they bind to host cells. This may
arise, for example, through immune modulators delivered by the
general secretary pathway, or the type I, II and V secretary
systems. For example, the well known virulence factor lysteriolysin
Oo fListeria monocytogenes and exotoxins of Staphylococcus aureus, are
secreted via the general secretory pathway [46]. We do not classify
between interactions with host and immune cells specifically since
we are concerned with how far the interaction occurs from the
infecting parasite, not with what cell the interaction occurs with.
Measuring virulence: Case fatality rate, ‘disease severity’
and incidence
To capture both the short and long term consequences of
pathogen infection on host health, we use case fatality rate and a
‘disease severity’ score to measure pathogen virulence. These are
two of the three criteria used to estimate ‘burden of disease’ in a
recent protocol for prioritising infectious disease in public health
[47].
We rated each pathogen according to its severity, as described
in Table 1. We gave a score of 0 to pathogens of average
importance, or pathogens for which a lack of data precluded
another score. Incidence data are the estimated mean number of
new cases per year in the USA. Case fatality rates are estimates of
fatality without treatment or co-morbidities and represent the
number of cases of a disease ending in death compared to the
number of cases of the disease. We obtained data from the before-
mentioned databases, plus various reports in the literature (see
Table S1 in Text S1).
We emphasise that while a ‘‘case’’ should represent an infected
individual, in practice it may involve infection of some severity, -
hospitalization even. Thus overall our definition of case fatality
may overestimate virulence. For example, a benign parasite that
infects many hosts asymptomatically, but cause severe disease in a
small proportion of hosts, may be classified as virulent. By contrast,
a virulent parasite that causes disease of equal severity in its hosts
may be classed as less virulent. To correct for this potential bias,
we assessed whether case fatality rate is linked to incidence rate,
and examined the effects of the other variables after controlling for
variation in incidence rate.
Transmission mode and route of infection
We obtained data on transmission mode and route of infection
using the before-mentioned databases. We classified pathogens as
either direct or indirectly transmitted: direct transmission requires
physical contact between an infected and susceptible host, and
indirect transmission requires an agent to transfer the pathogen
from an infected to a susceptible host. We classified the routes of
infection used by pathogens as entry through wounded skin,
inhalation, or ingestion. For example, Bordatella pertussis is usually
Figure 3. Variation in case fatality rate explained by infection
route. Means 61 standard error. Line represents a logistic curve (Table
S3 in Text S1).
doi:10.1371/journal.ppat.1002512.g003
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contact with susceptible others who then inhale the pertussis
bacteria [41] (i.e. direct transmission). Where pathogens can use
more than one mechanism of transmission or infection, we used
the mechanism stated in the infective dose data for our analyses.
Statistical analysis
We performed three analyses. First, we tested whether
minimum infective dose (log transformed) was related to the
mechanism of infection (2 level fixed factor: local or distant),
infection route (3 level fixed factor: ingestion, inhalation, wounded
skin) and the transmission mode of pathogens (2 level fixed factor:
direct, indirect) using a linear mixed effects model (LMM) with
restricted maximum likelihood estimation (REML). Second we
tested if case fatality rate (% of cases resulting in death) was
influenced by infective dose (covariate log transformed), incidence
(covariate log transformed), mechanism of infection, infection
route and transmission mode using a generalised linear mixed
effects model (GLMM) with a binomial error distribution. Finally,
we analysed the severity of infection (21, 0, 1) in relation to the
same explanatory variables as the second analysis using a GLMM
with an ordered multinomial error distribution.
The data (Table S1 in Text S1) encompass a diverse range of
pathogens. We obtained information on the taxonomic classifica-
tion of pathogens from the National Center for Biotechnology
Information (NCBI) [48]. We accounted for the non-indepen-
dence of data arising from phylogenetic relationships between
pathogens in all LMMs and GLMMs using nested taxonomic
random effects structures whereby each taxonomic level (genus,
order, class and kingdom) was nested within all higher taxonomic
levels (see Tables S2–4 in Text S1 for details). We only entered
genus, order, class and kingdom into models because of poor
replication at other taxonomic levels. We examined the signifi-
cance of fixed effects (factors and covariates) using Wald type
adjusted F statistics and the effect with the highest P value was
sequentially dropped until only significant terms (P,0.05)
remained [49]. Prior to all analyses covariates were Z-transformed
(mean=0, standard deviation=1). We used the Kenward and
Roger (1997) method for estimating standard errors for parameter
estimates and denominator degrees of freedom since it is
specifically designed for models with multiple random effects
and unbalanced data, increasing the accuracy of significance tests
[50–52]. We assessed the significance of random effects using log-
likelihood ratio tests (LRTs) [53]. All analyses were conducted in
SAS version 9.2.
Supporting Information
Text S1 Dataset and statistical analysis tables. Here we
provide details of the pathogens included in this study and
summaries of the statistical analysis: Table S1: Pathogens included
in the analysis; Table S2: LMM of infection dose; Table S3:
GLMM of case fatality rate; Table S4: GLMM of severity of
infection.
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